BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral activity assay of novel (E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine. 2003

Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Departamento de Química Orgánica e Inorgánica, Facultad de Química, Universidad de Oviedo, Oviedo, Spain.

(E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine (5), the diamino analogue of BVDU (1), was synthesized from BVDU. In contrast with BVDU, compound 5 did not show activity against herpes simplex virus or varicella-zoster virus.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D014753 Vinyl Compounds Compounds containing the vinyl (-C Compounds, Vinyl
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
February 1986, Journal of medicinal chemistry,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
May 1983, The Biochemical journal,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds.
January 1988, Journal of medicinal chemistry,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
September 2001, Antiviral chemistry & chemotherapy,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
August 1984, The Journal of antimicrobial chemotherapy,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
August 1989, Journal of medicinal chemistry,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine.
June 1981, Journal of medicinal chemistry,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Enantiospecific synthesis of carbocyclic (+)-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
January 1987, Nucleic acids symposium series,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.
February 1984, Nucleic acids research,
Iván Lavandera, and Susana Fernández, and Miguel Ferrero, and Erik De Clercq, and Vicente Gotor
Simple synthesis of novel acyclic (e)-bromovinyl nucleosides as potential antiviral agents.
January 2006, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!